Skip to content

What drugs can you not take with Wegovy?

3 min read

In a 68-week clinical trial, adults taking semaglutide lost an average of 14.9% of their body weight. Before starting, it is crucial to understand what drugs can you not take with Wegovy to avoid harmful interactions and ensure treatment effectiveness.

Quick Summary

Wegovy (semaglutide) can interact with several medications, altering their effects or increasing risks. Key interactions involve diabetes drugs like insulin, which can cause low blood sugar, and many oral medications due to delayed stomach emptying.

Key Points

  • Hypoglycemia Risk: Taking Wegovy with insulin, sulfonylureas, or meglitinides can cause dangerously low blood sugar.

  • Delayed Oral Drug Absorption: Wegovy slows stomach emptying, which can affect how oral medications, including contraceptives and thyroid medicine, are absorbed.

  • Avoid Other GLP-1s: Do not use Wegovy with other GLP-1 receptor agonists like Ozempic, Trulicity, or Victoza, as this increases side effects.

  • Thyroid Cancer Warning: People with a personal or family history of Medullary Thyroid Carcinoma (MTC) or MEN2 syndrome should not take Wegovy.

  • Full Disclosure is Crucial: Always provide your doctor with a complete list of all prescription drugs, OTC medications, and supplements you are taking.

  • Monitor for Pancreatitis: Be aware of symptoms of pancreatitis, such as severe abdominal pain, and contact a doctor if they occur.

  • Pregnancy Planning: Discontinue Wegovy at least two months before planning to become pregnant due to its long half-life and potential risk to a fetus.

In This Article

Wegovy (semaglutide) is an injectable medication used for chronic weight management that mimics the hormone GLP-1 to regulate appetite. A key effect of Wegovy is slowing gastric emptying, which can impact the absorption of other medications. It is important to inform your healthcare provider about all medications, vitamins, and supplements you are taking.

The Primary Mechanism: Delayed Gastric Emptying

By delaying the movement of food and contents from the stomach, Wegovy can alter the absorption of oral medications, potentially affecting their effectiveness or blood concentration.

Oral Medications

Because of the delay in gastric emptying, the absorption of various oral medications can be affected. This can be particularly important for drugs that require precise dosing and absorption. Examples include oral contraceptives, thyroid hormones like levothyroxine, certain antibiotics, and the blood thinner warfarin. Monitoring and timing adjustments may be necessary for these and other oral drugs.

Significant Drug Interactions

Certain drug classes have notable interactions with Wegovy that can pose health risks.

Diabetes Medications

Combining Wegovy with other medications that lower blood sugar can significantly increase the risk of hypoglycemia (low blood sugar).

  • Insulin: Taking insulin with Wegovy raises the risk of hypoglycemia. Dose adjustments and increased blood sugar monitoring may be required.
  • Sulfonylureas: Oral diabetes medications like glipizide or glyburide also increase the risk of low blood sugar when used with Wegovy. Dose reduction of the sulfonylurea might be needed.
  • Meglitinides: Medications such as repaglinide can also increase the risk of hypoglycemia when combined with Wegovy.

Symptoms of hypoglycemia can include dizziness, shakiness, sweating, and confusion.

Other GLP-1 Receptor Agonists

Wegovy should not be used concurrently with other GLP-1 receptor agonists, including other products containing semaglutide (like Ozempic or Rybelsus) or other GLP-1 drugs such as Victoza or Trulicity. This combination does not offer additional benefits and increases the likelihood of side effects like nausea and vomiting.

Wegovy Drug Interaction Comparison Table

Drug Class Examples Potential Interaction Management Strategy
Insulin Insulin glargine (Lantus), Insulin lispro (Humalog) Increased risk of severe hypoglycemia (low blood sugar). Your doctor may reduce your insulin dose and require frequent blood sugar monitoring.
Sulfonylureas Glipizide (Glucotrol XL), Glyburide (Diabeta), Glimepiride (Amaryl) Increased risk of hypoglycemia. Your doctor may lower the dose of the sulfonylurea and advise on monitoring for low blood sugar.
Other GLP-1 Agonists Liraglutide (Victoza, Saxenda), Dulaglutide (Trulicity) Increased risk of gastrointestinal side effects and redundant therapy. Coadministration is not recommended. Inform your doctor if you are taking another GLP-1 drug.
Oral Medications (General) Oral contraceptives, Levothyroxine, certain antibiotics Delayed or altered absorption, potentially reducing effectiveness. Discuss the timing of all oral medications with your doctor. Monitoring may be required for certain drugs.

Who Should Not Take Wegovy? (Contraindications)

Wegovy is not suitable for everyone. Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use it. A history of a serious allergic reaction to semaglutide or its components is also a contraindication. If you have a history of pancreatitis, discuss this with your doctor as the risk is uncertain. Wegovy is not recommended during pregnancy and should be stopped at least two months beforehand.

Conclusion

Wegovy is an effective weight management medication, but it's important to be aware of potential drug interactions. The main concerns involve an increased risk of low blood sugar when taken with other diabetes medications and the potential for altered absorption of oral drugs due to slowed gastric emptying. Always provide your healthcare provider with a complete list of all medications and supplements to ensure your treatment is safe and effective.

For more detailed information, you can review the FDA's official prescribing information for Wegovy.

Frequently Asked Questions

You should not take Wegovy with other GLP-1 receptor agonists, including other semaglutide products like Ozempic. Doing so is not recommended as it increases the risk of side effects such as nausea, vomiting, and diarrhea, without providing additional benefit.

Yes, but with caution. The combination significantly increases the risk of hypoglycemia (low blood sugar). Your healthcare provider will likely reduce your insulin dose and advise you to monitor your blood glucose levels closely.

Wegovy slows stomach emptying, which can potentially impact the absorption of oral medications, including contraceptives. It is important to discuss this with your doctor, who may advise on timing or additional contraceptive methods.

While there is no direct interaction, Wegovy itself can lower blood pressure. If you are taking antihypertensive drugs, this combination might cause your blood pressure to drop too low. Certain blood pressure medications like ACE inhibitors can also increase the risk of low blood sugar when taken with Wegovy. Your doctor should monitor your blood pressure and blood sugar.

Wegovy's delay of gastric emptying can affect the absorption of levothyroxine. Research indicates semaglutide can increase total levothyroxine exposure. Your doctor may recommend more frequent monitoring of your thyroid function to ensure your levels remain stable.

You should not take Wegovy if you have a personal or family history of medullary thyroid carcinoma (MTC), an endocrine condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or a known severe allergy to semaglutide.

There are no reported interactions with most vitamins. However, Wegovy may interact with chromium supplements, as both can lower blood sugar levels. It is always best to discuss all supplements, including herbal ones like St. John's Wort or ginseng, with your doctor before starting Wegovy.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.